PJ Online | News feature: How the new tiered contract for community pharmacy is being built
The Pharmaceutical Journal
How the new tiered contract for community pharmacy is being built
A new tiered contract for community pharmacy has been proposed by the PSNC. Clare Bellingham (on the staff of The Journal) finds out more about the proposals
If all goes to plan, pharmacy's new contract is less than a year away. The target implementation date is April 2004. First, however, before the contract is finalised, the Pharmaceutical Services Negotiating Committee has to strike a good deal for pharmacy with the Department of Health and the NHS Confederation (which represents the interests of primary care organisations).
So what has the PSNC come up with? It proposes a tiered structure of essential, enhanced and additional services (see Panel below).
Initially, all contractors will just offer essential services. Enhanced services will be gradually introduced with the eventual aim that all contractors will offer these services and they will become part of the essential package. Additional services fit on top and contractors will be able to negotiate which of these they offer.
The reason for separating enhanced services from the essential services to begin with is that training, accreditation or new facilities might be needed before they can be offered. A gradual introduction of enhanced services means that pharmacists will be able to undertake training and develop their premises over time.
On top of the basic package of essential services, pharmacists will have the option to offer additional services. Such services will be commissioned by primary care organisations, according to local needs. However, the specification for these services, including their prices, will be agreed nationally. This offers pharmacists and PCOs the potential to develop new and innovative services.
The PSNC views the contract as something that will develop over time. Some services that currently fall into its enhanced section might, in the future, become essential services. And, as more additional services are developed, national specifications for these could be negotiated. The committee hopes that this will allow the contract to change according to the needs of patients, the National Health Service and the profession.
What fits where
Perhaps not surprisingly, dispensing is an essential service. The PSNC has stressed that dispensing is central to the new contract. It says that the dispensing service will include giving advice to patients about the medicine dispensed and interactions with other medicines; making a record of the medicine dispensed and, possibly, any advice given; and providing compliance aids needed by disabled patients.
Repeat dispensing is also an essential service, and marks a development from pharmacists' current role. The PSNC defines this role as "the management of the repeat dispensing process in partnership with the patient and prescriber". It is envisaged this will involve ascertaining that the patient needs a repeat supply of medicine. The pharmacist should then be able to alter the quantity of medicines to allow synchronisation and also to make substitutions when the patient is prescribed, eg, two low-dose tablets where one higher-dose tablet provides the same dose. Pharmacists would then be expected to communicate all significant issues to the prescriber, including, if appropriate, any suggestions of changes to medication. Finally, the pharmacist should give advice about when a medication review is due and educate patients about ordering repeat medicines to prevent wastage.
Another essential service is a role in public health. This will involve many aspects of promoting a healthy lifestyle, for example, advice on smoking cessation, appropriate use of antibiotics, promoting influenza vaccination uptake and suggesting patients undertake appropriate disease monitoring.
Waste disposal, of both medicines and sharps, is seen as an essential service, as is referring patients to other health care professionals, where appropriate. Clinical governance including using standard operating procedures, undertaking continuing professional development and reporting adverse incidents to the National Patient Safety Agency is also classed an essential service.
The PSNC suggests one service in the enhanced category. It is "medicines use review". The aim of such a review is to assess any problems patients have with their medicine and to develop patients' knowledge about their regimens. Such reviews will fulfil national targets on reviews such as those in the National Service Framework for Older People.
Where management of minor ailments fits in is unclear. It could be either an essential or an additional service. It would involve some patients being able to get advice and treatment for minor ailments from the pharmacist but paid for by the NHS. This transfer of care would relieve some pressure on general practitioners, something that is specified in the GP contract.
Many examples of additional services exist. They will have to be agreed with PCOs and will be dependent on local need. A substance misuse service might be perfect for one town but unnecessary in another. Likewise, sufficient need might exist for only one pharmacy in a town to offer an anticoagulant service while another could have a role in home care services. This tailoring will be negotiated at a local level allowing scope for pharmacists to develop services in the way they choose. Some PCTs might be more limited in the services they will fund, perhaps dictated by particular local health issues.
Negotiating the financial side of the contract is further down the line.
What is in the contract needs to be agreed first. This decision will follow a period of consultation, and roadshows are currently taking place. The PSNC has stressed more than once that this is a "genuine consultation" and the contract described above is a proposal. Contractors voices will be listened to and alterations made as appropriate.
A ballot will be held later this year to determine if the basic structure is right. It is not until this point that talks over the fine details will be reached.
This is where the financial negotiations will start. However, a basic formula for funding has been proposed (see Panel above right).
In addition, an inquiry into the cost of service is currently under way. A survey of 470 contractors was carried out at the end of June to determine costs of staff, property and other overheads. The PSNC will use this information in negotiations over funding the new contract.
Proposing this new contract is not the end of the battle: the PSNC still faces months of hard work. There are negotiations with the Department of Health and NHS Confederation, and a fair number of dilemmas to solve (see below). But let us hope that this new tiered contract is a step towards recognising the professional roles that pharmacists can offer.
* PDF files on PJ Online require Acrobat Reader 4 or later
Citation: The Pharmaceutical Journal URI: 20009907
Recommended from Pharmaceutical Press